Harbinger Health’s Steve Hahn on the science of early cancer Dx after raising a $140M Series B
Steve Hahn describes how Harbinger Health is trying to catch the earliest signals of cancer, and how physicians and patients might use this information.
top of page
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
Popular
#1. Pfizer’s CEO on Q2 earnings.
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square
bottom of page